The biotech reported data from KOASTAL-1, the first of three phase 3 trials of navacaprant in major depressive disorder. Investigators randomized 383 people to receive the oral kappa opioid ...
Winning one Super Bowl is tough. Winning two? That’s legendary. But what about making it to three in a row? That’s a feat reserved for a select few teams in NFL history. With the Kansas City ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback